The Beauty Health Company

The Beauty Health Company

Consumer Defensive

NASDAQ:SKIN · NASDAQ Capital Market

Market Cap $83.15M Beta 1.07 P/E (TTM) -13.9
$0.65 +1.90%

+$0.01 today

52W Low $0.55High $2.69

Vol 0.39M · Avg 0.99M

EPS (TTM)-$0.05
Household & Personal Products

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

-15.6%

avg -13.3%

ROIC

-4.7%

avg -5.0%

ROA

-1.9%

avg -7.2%

Analysis

ROA is currently the strongest return metric at -1.9% versus its period average of -7.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

Michael Monahan

Chief Financial Officer$1.23M54$1.99M1.53%

Pedro Malha

President, Chief Executive Officer & Director$966,787.0054$4.85M3.74%

Sheri Lewis

Chief Operations, Quality & Technology Officer$931,142.0060$1.58M1.22%

Ronald Menezes

Chief Revenue Officer & Executive Officer$895,692.0062$1.76M1.36%

Paul Bokota

Senior Vice President & General Counsel

Whitney Cypes

Chief Brand & Clinical Innovation Officer

Insider Trading

SEC Form 4 transactions — last 12 months

Management

No insider transactions in the last 12 months.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A3 analysts
RevenueN/AN/A+30.0%
-2.6% (6yr)3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Recent growth has been strongest in Revenue at +30.0% over three years. Forward estimates point to Revenue at -2.6% (6yr), giving you a quick check on whether expectations are accelerating or cooling.

Who manages SKIN?

The Beauty Health Company (SKIN) lists 6 active executives. The top listed executive is Ronald Menezes, Chief Revenue Officer & Executive Officer.

Are SKIN insiders buying or selling?

Recent insider activity shows net buying of $45.19M.

Explore More

Continue the stock analysis

Jump to another research area for this company.